Factors associated with diagnostic accuracy when performing a preablation renal biopsy

Gideon Lorber, Merce Jorda, Raymond Leveillee

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background and Purpose: Long-term treatment of patients undergoing definitive management of a small renal mass depends largely on the final pathology determination. Preablation renal biopsy (PABx) is often the only source of determining pathology in patients undergoing thermal ablation of a small renal mass. We sought to evaluate patient and tumor characteristics that may play a role in determining the accuracy of a PABx obtained during radiofrequency ablation (RFA).

Methods: This retrospective study included a review of our prospectively collected database of all laparoscopic and CT-guided RFA (LRFA; CTRFA) performed in our center from November 2001 to July 2013. Three 18-gauge core biopsies were obtained per tumor. Pathology samples were stratified into diagnostic (group 1) and nondiagnostic (ND) (group 2). We used univariate and multivariate analysis to identify potential biopsy result-modifying factors including patient characteristics (age, body mass index [BMI]), biopsy approach (CTRFA vs LRFA), tumor size, orientation, depth, and polarity.

Results: A total of 463 treatments in 411 patients were evaluated. Of these, 66% were CTRFA while 34% were LRFA. Mean patient age was 67.4 years (31-88), mean BMI was 28.3 kg/m2 (16.6-47.2), and mean tumor size was 2.6cm (0.3-5.5). There was a total of 73 (15.8%) ND biopsies. On multivariate analysis, CTRFA and medial tumors managed with either CTRFA or LRFA were found to be associated with an increased likelihood of a ND biopsy. Conclusion: PABx obtained in patients undergoing CTRFA and from medial tumors managed with either CTRFA or LRFA were more likely to be ND. Future RFA patients should be counseled appropriately. Additional biopsy cores may be needed in these subgroups. Further prospective studies are warranted to confirm these findings.

Original languageEnglish
Pages (from-to)1444-1447
Number of pages4
JournalJournal of Endourology
Volume28
Issue number12
DOIs
StatePublished - Jan 1 2014

Fingerprint

Kidney
Biopsy
Neoplasms
Pathology
Body Mass Index
Multivariate Analysis
Retrospective Studies
Hot Temperature
Databases
Prospective Studies
Therapeutics

ASJC Scopus subject areas

  • Urology

Cite this

Factors associated with diagnostic accuracy when performing a preablation renal biopsy. / Lorber, Gideon; Jorda, Merce; Leveillee, Raymond.

In: Journal of Endourology, Vol. 28, No. 12, 01.01.2014, p. 1444-1447.

Research output: Contribution to journalArticle

Lorber, Gideon ; Jorda, Merce ; Leveillee, Raymond. / Factors associated with diagnostic accuracy when performing a preablation renal biopsy. In: Journal of Endourology. 2014 ; Vol. 28, No. 12. pp. 1444-1447.
@article{0803979a90004a028ef0e98f4c9f8b93,
title = "Factors associated with diagnostic accuracy when performing a preablation renal biopsy",
abstract = "Background and Purpose: Long-term treatment of patients undergoing definitive management of a small renal mass depends largely on the final pathology determination. Preablation renal biopsy (PABx) is often the only source of determining pathology in patients undergoing thermal ablation of a small renal mass. We sought to evaluate patient and tumor characteristics that may play a role in determining the accuracy of a PABx obtained during radiofrequency ablation (RFA).Methods: This retrospective study included a review of our prospectively collected database of all laparoscopic and CT-guided RFA (LRFA; CTRFA) performed in our center from November 2001 to July 2013. Three 18-gauge core biopsies were obtained per tumor. Pathology samples were stratified into diagnostic (group 1) and nondiagnostic (ND) (group 2). We used univariate and multivariate analysis to identify potential biopsy result-modifying factors including patient characteristics (age, body mass index [BMI]), biopsy approach (CTRFA vs LRFA), tumor size, orientation, depth, and polarity.Results: A total of 463 treatments in 411 patients were evaluated. Of these, 66{\%} were CTRFA while 34{\%} were LRFA. Mean patient age was 67.4 years (31-88), mean BMI was 28.3 kg/m2 (16.6-47.2), and mean tumor size was 2.6cm (0.3-5.5). There was a total of 73 (15.8{\%}) ND biopsies. On multivariate analysis, CTRFA and medial tumors managed with either CTRFA or LRFA were found to be associated with an increased likelihood of a ND biopsy. Conclusion: PABx obtained in patients undergoing CTRFA and from medial tumors managed with either CTRFA or LRFA were more likely to be ND. Future RFA patients should be counseled appropriately. Additional biopsy cores may be needed in these subgroups. Further prospective studies are warranted to confirm these findings.",
author = "Gideon Lorber and Merce Jorda and Raymond Leveillee",
year = "2014",
month = "1",
day = "1",
doi = "10.1089/end.2014.0222",
language = "English",
volume = "28",
pages = "1444--1447",
journal = "Journal of Endourology",
issn = "0892-7790",
publisher = "Mary Ann Liebert Inc.",
number = "12",

}

TY - JOUR

T1 - Factors associated with diagnostic accuracy when performing a preablation renal biopsy

AU - Lorber, Gideon

AU - Jorda, Merce

AU - Leveillee, Raymond

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Background and Purpose: Long-term treatment of patients undergoing definitive management of a small renal mass depends largely on the final pathology determination. Preablation renal biopsy (PABx) is often the only source of determining pathology in patients undergoing thermal ablation of a small renal mass. We sought to evaluate patient and tumor characteristics that may play a role in determining the accuracy of a PABx obtained during radiofrequency ablation (RFA).Methods: This retrospective study included a review of our prospectively collected database of all laparoscopic and CT-guided RFA (LRFA; CTRFA) performed in our center from November 2001 to July 2013. Three 18-gauge core biopsies were obtained per tumor. Pathology samples were stratified into diagnostic (group 1) and nondiagnostic (ND) (group 2). We used univariate and multivariate analysis to identify potential biopsy result-modifying factors including patient characteristics (age, body mass index [BMI]), biopsy approach (CTRFA vs LRFA), tumor size, orientation, depth, and polarity.Results: A total of 463 treatments in 411 patients were evaluated. Of these, 66% were CTRFA while 34% were LRFA. Mean patient age was 67.4 years (31-88), mean BMI was 28.3 kg/m2 (16.6-47.2), and mean tumor size was 2.6cm (0.3-5.5). There was a total of 73 (15.8%) ND biopsies. On multivariate analysis, CTRFA and medial tumors managed with either CTRFA or LRFA were found to be associated with an increased likelihood of a ND biopsy. Conclusion: PABx obtained in patients undergoing CTRFA and from medial tumors managed with either CTRFA or LRFA were more likely to be ND. Future RFA patients should be counseled appropriately. Additional biopsy cores may be needed in these subgroups. Further prospective studies are warranted to confirm these findings.

AB - Background and Purpose: Long-term treatment of patients undergoing definitive management of a small renal mass depends largely on the final pathology determination. Preablation renal biopsy (PABx) is often the only source of determining pathology in patients undergoing thermal ablation of a small renal mass. We sought to evaluate patient and tumor characteristics that may play a role in determining the accuracy of a PABx obtained during radiofrequency ablation (RFA).Methods: This retrospective study included a review of our prospectively collected database of all laparoscopic and CT-guided RFA (LRFA; CTRFA) performed in our center from November 2001 to July 2013. Three 18-gauge core biopsies were obtained per tumor. Pathology samples were stratified into diagnostic (group 1) and nondiagnostic (ND) (group 2). We used univariate and multivariate analysis to identify potential biopsy result-modifying factors including patient characteristics (age, body mass index [BMI]), biopsy approach (CTRFA vs LRFA), tumor size, orientation, depth, and polarity.Results: A total of 463 treatments in 411 patients were evaluated. Of these, 66% were CTRFA while 34% were LRFA. Mean patient age was 67.4 years (31-88), mean BMI was 28.3 kg/m2 (16.6-47.2), and mean tumor size was 2.6cm (0.3-5.5). There was a total of 73 (15.8%) ND biopsies. On multivariate analysis, CTRFA and medial tumors managed with either CTRFA or LRFA were found to be associated with an increased likelihood of a ND biopsy. Conclusion: PABx obtained in patients undergoing CTRFA and from medial tumors managed with either CTRFA or LRFA were more likely to be ND. Future RFA patients should be counseled appropriately. Additional biopsy cores may be needed in these subgroups. Further prospective studies are warranted to confirm these findings.

UR - http://www.scopus.com/inward/record.url?scp=84915785027&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84915785027&partnerID=8YFLogxK

U2 - 10.1089/end.2014.0222

DO - 10.1089/end.2014.0222

M3 - Article

VL - 28

SP - 1444

EP - 1447

JO - Journal of Endourology

JF - Journal of Endourology

SN - 0892-7790

IS - 12

ER -